Whereas reconstruction of wild-type CDH1 in human breast cancer cell line MDA-MB-231 didn’t revert the morphology of the human cells [28], treating this cells with the ADAM10 specific inhibitor, GI 254023X showed a reduced migration without effecting cell numbers [57]. The gene discussed is CDH1; the disease is breast carcinoma.